Skip to main content
ZIM Laboratories Limited logo

ZIM Laboratories Limited — Investor Relations & Filings

Ticker · ZIMLAB ISIN · INE518E01015 LEI · 335800YPYG1O3ML66R52 BSE.NS Manufacturing
Open in API
Filings indexed 423 across all filing types
Latest filing 2023-08-21 Call Transcript
Country IN India
Listing BSE.NS ZIMLAB

About ZIM Laboratories Limited

https://www.zimlab.in/

ZIM Laboratories Limited is a research-driven organization specializing in the development and manufacturing of innovative drug delivery solutions. The company focuses on enhancing the efficacy and patient compliance of generic medicines through advanced formulation technologies. Its core product portfolio includes Oral Disintegrating Films (ODF), Oral Disintegrating Tablets (ODT), pellets, and taste-masked granules. Utilizing proprietary technology platforms like Thinoral, the company provides differentiated products across various therapeutic segments, including central nervous system, cardiovascular, and gastrointestinal health. ZIM Laboratories offers end-to-end services from product development and clinical trials to commercial manufacturing. The organization serves a global clientele, providing value-added generic formulations that address specific patient needs such as ease of administration and rapid onset of action.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of the Q1 FY24 earnings conference call of ZIM Laboratories Limited held on August 16, 2023. It includes management presentations, financial results discussion, business outlook, and a Q&A session with analysts and investors. The text explicitly mentions it is a transcript of the earnings call, which is a full text record of the conference call event. This matches the definition of a Call Transcript (CT). The document is lengthy (15,000 characters) and contains substantive content beyond a mere announcement or summary, confirming it is not an Earnings Release or Report Publication Announcement. Therefore, the correct classification is CT with high confidence.
2023-08-21 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short letter dated 16.08.2023 from ZIM Laboratories Limited addressed to stock exchanges, informing them about the availability of the audio recording of the Q1 FY24 Earnings Conference Call on the company's website. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, which pertains to disclosure requirements. The document does not contain the transcript or detailed financial data but only announces the availability of the audio recording. The length is only 2115 characters, which is quite short and consistent with an announcement rather than the full transcript. According to the classification rules, a document that announces the availability of a call transcript or recording without including the full transcript should be classified as a Regulatory Filing (RNS) because it is a general regulatory announcement and does not contain the full call transcript itself.
2023-08-16 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding the newspaper publication of financial results for the quarter ended 30.06.2023. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 47, which mandates the publication of financial results in newspapers. The document includes copies of the newspaper publications of the quarterly financial results but does not contain the actual financial statements or detailed financial data itself. The document is essentially an announcement or intimation to the stock exchanges that the financial results have been published in newspapers. It is not the financial report itself (such as an Interim/Quarterly Report) but a notification about the publication of such results. Therefore, according to the MENU VS MEAL rule, this document should be classified as a Regulatory Filing (RNS) because it is a regulatory announcement about the publication of financial results, not the report itself.
2023-08-16 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is titled 'Q1FY24 Earnings Presentation August 2023' and is addressed as an earnings presentation. It contains detailed financial data for the first quarter of fiscal year 2024, including income statement figures, operational updates, business overview, and strategic initiatives. The document is about 15,000 characters long, indicating it is a full presentation rather than a brief announcement. The content includes forward-looking statements, financial highlights, and business strategy, which are typical of an investor presentation. It is not a formal earnings release (which would be shorter and more summary-focused), nor is it a full annual or interim report with comprehensive financial statements. Therefore, the document fits the category of an Investor Presentation (IP).
2023-08-14 English
Financial Result Updates
Regulatory Filings
2023-08-14 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is an intimation regarding the loss of share certificates and the consequent stop transfer action taken by the Registrar and Share Transfer Agent (RTA) of the company. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 39(3), which pertains to share certificate loss and stop transfer instructions. The document is a formal notification to stock exchanges about this administrative action. It does not contain financial statements, audit information, management discussion, or any report data. It is not a report itself but a regulatory announcement related to share certificate status and transfer restrictions. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous compliance and regulatory announcements that do not fit other specific categories.
2023-08-12 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.